Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 1Lung Neoplasms 1Lung Diseases 1Colorectal Neoplasms 1Breast Neoplasms 1Adenomatous Polyps 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Diarylheptanoids × Clear all
NCT06626230 2026-05-18

Safety of Anal Curcumin

Emory University

Phase 1 Recruiting
48 enrolled
Tumor-Agnostic

Neoplasms

NCT03598309 2026-02-27

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
19 enrolled
Thoracic

Lung Diseases, Lung Neoplasms

NCT00118989 2017-04-20

Curcumin for the Chemoprevention of Colorectal Cancer

University of Pennsylvania

Phase NA Terminated
56 enrolled
Gastrointestinal

Colorectal Neoplasms, Adenomatous Polyps

NCT01042938 2012-06-25

Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients

University of Rochester

Phase 2 Completed
35 enrolled 9 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡